Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide

Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide

US Patent 9757355 · Granted Sep 12, 2017

Estimated economic value: $288,213,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Probiotic compositions and uses thereof2025
Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl2024
Silicon photonics optical transceiver device2024
Method for preparing nicotinamide mononucleotide cocrystal2024
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindo2024
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-y2023
Heteroaryl compounds useful as MK2 inhibitors2023
Skin penetration enhancing composition and use thereof in preparation of skin de2022
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione2022
Optical transceiver module and optical cable module2022
Optical transceiver module and optical cable module2022
Deuterated analogs of MK2 inhibitors and uses thereof2022